Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06496425 · ClinicalTrials.gov registry record · NA

Inspiring Seniors Towards Exercise Promotion to Protect Cognition

A NA study of Alzheimer Disease and Physical Activity, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT06496425: Recruiting NA study of Alzheimer Disease and Physical Activity, sponsored by Emory University.

NCT06496425 is a NA study of Alzheimer Disease and Physical Activity that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06496425, a NA study of Alzheimer Disease and Physical Activity, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to test the benefits of beat-accented music stimulation (BMS) for behavioral changes of physical activity (PA) in older adults with subjective memory complaints. Specific Aims are to determine (1) whether BMS beneficially influences PA behaviors and psychological responses to PA in older adults for 6 months, and (2) whether exercising with BMS differently influences physical and cognitive functioning as well as quality of life in older adults.To test the effects of BMS on PA, participants will be randomly assigned to an exercise intervention that either includes BMS or does not include BMS. Participants will attend a supervised group strength training (ST) (30 min/day) and and aerobic exercise (AE) (30-50 min/day) session for 3 days/week for the first 2 months, 1 day/week for the next 2 months (while encouraging participants to independently perform both AE and ST on other days), and independently for the final 2 months (always with a goal of performing \>150min/week AE and 3 days/week of ST for 30 min/day).

Primary Outcome

Duration, intensity, and frequency of physical activity assessed using a waist-worn accelerometer.

Interventions

  • BEHAVIORAL Music

Study Locations (2)

Georgia

  • Emory University - Atlanta

North Carolina

  • UNC Greensboro - Greensboro

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-05-15
Est. Completion 2026-10
Phase NA
Emory University

1,208 total trials

What NCT06496425 shows while recruiting

NCT06496425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Music is the first listed.

NCT06496425 reports a single indexed study location in Georgia, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06496425 about?

NCT06496425 is a clinical study titled "Inspiring Seniors Towards Exercise Promotion to Protect Cognition". The goal of this clinical trial is to test the benefits of beat-accented music stimulation (BMS) for behavioral changes of physical activity (PA) in older adults with subjective memory complaints. Specific Aims are to determine (1) whether BMS beneficially influences PA behaviors and psychological r...

What is the current status of trial NCT06496425?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-05-15. Estimated completion is 2026-10.

What conditions does trial NCT06496425 study?

This clinical trial studies the following conditions: Alzheimer Disease, Physical Activity.

What interventions are being tested in trial NCT06496425?

The interventions under investigation include: Music (BEHAVIORAL).

Who is sponsoring clinical trial NCT06496425?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06496425 being conducted?

This trial has 2 study locations across Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06496425's enrollment target sits among peer trials

80 168th of 306 higher than 134 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06496425, the US trial registry maintained by the National Library of Medicine. NCT06496425 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.